Spoken Alpha
BBNX
Beta Bionics, Inc.
Overview
Beta Bionics, Inc is a Healthcare company operating in Medical Devices with a $610.5M market cap.
Most recent reported earnings: Q2 FY2026 (Aug 3, 2026).
5 earnings calls indexed on Spoken Alpha.
Behavioral analysis
Management language signature
Disclosures
Investor Relations
Extracted from Unknown source, 2026-06-21.
Transcripts
Recent earnings calls
Most recent calls indexed for this ticker. Open any call to drill into prepared remarks and Q&A.
History
Earnings history
- Q2 FY20262026-08-03EPS— vs $-0.62—Rev— vs ——EODHD
| Period | Reported | EPS actual | EPS consensus | EPS surprise | Revenue actual | Revenue consensus | Rev. surprise | Source |
|---|---|---|---|---|---|---|---|---|
| Q2 FY2026 | 2026-08-03 | — | $-0.62 | — | — | — | — | EODHD |
Source: EODHD. BBNX reported actuals as published; sparse fields render as —.
Track Record
SampleSpoken Alpha tracks BBNX's historical accountability: how often management beat consensus, how the stock reacted, and how guidance evolved across the cycle. The figures below are illustrative placeholder data generated for layout — they will be replaced with real deviation metrics, True Consensus values, and EODHD price reactions as those data layers land.
Misses consensus 10/10 quarters
SampleRepeated misses without a guidance reset suggest management is structurally optimistic relative to operating reality. Track whether next-quarter guidance is being benchmarked off the prior miss or the prior plan.
Missed in 4 of the last 4 quarters
SampleRecent misses matter more than long-window beat rate — the trailing 12 months drives the analyst model and the next-print bar.
Quarterly beats & misses
Sample| Quarter | Actual EPS | Consensus | Surprise | 1D | 5D |
|---|---|---|---|---|---|
| Q1 FY2026 | $3.26 | $3.73 | -12.7% | +0.5% | +0.4% |
| Q4 FY2026 | $3.64 | $3.83 | -4.9% | +2.1% | +1.7% |
| Q3 FY2026 | $3.11 | $3.66 | -15.1% | +0.9% | -0.7% |
| Q2 FY2026 | $3.31 | $3.80 | -12.8% | +7.5% | +9.6% |
| Q1 FY2025 | $3.64 | $3.83 | -4.9% | +1.5% | +3.0% |
| Q4 FY2025 | $3.55 | $3.85 | -7.8% | +1.4% | +2.2% |
| Q3 FY2025 | $3.16 | $3.93 | -19.6% | +1.7% | +1.5% |
| Q2 FY2025 | $3.67 | $3.92 | -6.3% | +7.6% | +7.9% |
| Q1 FY2024 | $3.60 | $3.83 | -6.0% | -1.0% | -2.6% |
| Q4 FY2024 | $3.57 | $3.93 | -9.2% | -1.4% | +1.3% |
Guidance change history
Sample- Q1 FY2026Lowered2026-04-15
- Q4 FY2026Lowered2026-13-15
- Q3 FY2026Lowered2026-10-15
- Q2 FY2026Lowered2026-07-15
- Q1 FY2025Lowered2025-04-15
- Q4 FY2025Lowered2025-13-15
- Q3 FY2025Lowered2025-10-15
- Q2 FY2025Lowered2025-07-15
Top executives
SampleSpoken Alpha builds an accountability record per executive — how the person's own guidance, language, and reactions have evolved across every call they've appeared on. The one-liners below are illustrative placeholder data pending the deviation v1 work. Click any name for the full role timeline and call appearance history.
- Sean SaintCEO9 mo5 callsCurrentSample
CEO since 2025 • 2/4 beats (50%) • last guidance raise Q2 FY2026
- Stephen FeiderCFO10 mo5 callsCurrentSample
CFO since 2025 • 2/4 beats (50%) • guidance suspended Q2 FY2026
- Mark HopmanChief Commercial Officer9 mono recorded callsCurrentSample
OTHER_C_SUITE since 2025 • 2/4 beats (50%) • last guidance cut Q2 FY2026
- Steven Jon RussellChief Medical Officer9 mono recorded callsCurrentSample
OTHER_C_SUITE since 2025 • 2/4 beats (50%) • last call held guidance Q3 FY2026
- Mike MensingerChief Product Officer9 mono recorded callsCurrentSample
OTHER_C_SUITE since 2025 • 2/4 beats (50%) • last guidance cut Q3 FY2026
Peers
Other companies in Healthcare
Sector peers tracked by Spoken Alpha. Each links to the same machine-readable IR surface — earnings calls, executives, and accountability scores.
API
For developers and AI agents
The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for BBNX.
$ curl https://api.spokenalpha.com/v1/companies/BBNXFAQ
Frequently asked about BBNX
Where can I find Beta Bionics, Inc.'s (BBNX) earnings call transcripts?
Spoken Alpha indexes BBNX's earnings call transcripts at https://spokenalpha.com/companies/BBNX. Each call links to attributed speakers and parsed analyst Q&A.
When was Beta Bionics, Inc.'s most recent earnings call?
Beta Bionics, Inc. (BBNX) held its most recent earnings call on 2026-04-21, covering fiscal Q1 2026.
What sector is BBNX in?
Beta Bionics, Inc. (BBNX) operates in the Healthcare sector (Medical Devices industry).